Peter Verhamme to Aged, 80 and over
This is a "connection" page, showing publications Peter Verhamme has written about Aged, 80 and over.
Connection Strength
0.075
-
Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2-azithromycin trial. Trials. 2021 Feb 09; 22(1):126.
Score: 0.006
-
Accuracy of age-adjusted D-dimer to rule out deep vein thrombosis in the elderly. Thromb Res. 2019 02; 174:148-150.
Score: 0.006
-
Management of major bleeding and outcomes in patients treated with direct oral anticoagulants: results from the START-Event registry. Intern Emerg Med. 2018 Oct; 13(7):1051-1058.
Score: 0.005
-
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J. 2018 04 21; 39(16):1330-1393.
Score: 0.005
-
Targeting Coagulase Activity in Staphylococcus aureus Bacteraemia: A Randomized Controlled Single-Centre Trial of Staphylothrombin Inhibition. Thromb Haemost. 2018 05; 118(5):818-829.
Score: 0.005
-
Validation of a prognostic score for hidden cancer in unprovoked venous thromboembolism. PLoS One. 2018; 13(3):e0194673.
Score: 0.005
-
Epidemiological and histological findings implicate matrix Gla protein in diastolic left ventricular dysfunction. PLoS One. 2018; 13(3):e0193967.
Score: 0.005
-
Reproducibility of Retinal Microvascular Traits Decoded by the Singapore I Vessel Assessment Software Across the Human Age Range. Am J Hypertens. 2018 03 10; 31(4):438-449.
Score: 0.005
-
Glomerular function in relation to circulating adhesion molecules and inflammation markers in a general population. Nephrol Dial Transplant. 2018 03 01; 33(3):426-435.
Score: 0.005
-
Impact of Thrombus Sidedness on Presentation and Outcomes of Patients with Proximal Lower Extremity Deep Vein Thrombosis. Semin Thromb Hemost. 2018 Jun; 44(4):341-347.
Score: 0.005
-
Impact of age, comorbidity, and polypharmacy on the efficacy and safety of edoxaban for the treatment of venous thromboembolism: An analysis of the randomized, double-blind Hokusai-VTE trial. Thromb Res. 2018 02; 162:7-14.
Score: 0.005
-
Age-adjusted D-dimer to rule out deep vein thrombosis: findings from the PALLADIO algorithm. J Thromb Haemost. 2018 02; 16(2):271-278.
Score: 0.005
-
Idarucizumab for Dabigatran Reversal - Full Cohort Analysis. N Engl J Med. 2017 08 03; 377(5):431-441.
Score: 0.005
-
Low-Dose and Slow-Infusion Thrombolysis for Prosthetic Valve Thrombosis After a Transcatheter Valve in the Mitral Position. JACC Cardiovasc Interv. 2017 04 10; 10(7):738-739.
Score: 0.005